The Economic Contribution of Industry-Sponsored Pharmaceutical Clinical Trials

Purpose: In pharmaceutical clinical trials, industrial sponsors pay for study drugs and related healthcare services. We conducted a study to determine industry’s economic contribution of these trials to the Alberta healthcare system.

Authors and Affiliations:

Dat T. Tran1,2; Ilke Akpinar2 ; Richard N. Fedorak3 ; Egon Jonsson2 ; John R. Mackey4 ; Lawrence Richer5 ; Philip Jacobs2,3

  1. School of Public Health, University of Alberta;
  2. Institute of Health Economics;
  3. Department of Medicine, University of Alberta;
  4. Department of Oncology, University of Alberta;
  5. Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada

Funding:

This study was funded by Alberta Innovates Health Solutions.

Partners:

Institute of Health Economics, University of Alberta, Alberta Innovates

Publication Type: Journal Articles

Year of Publication: 2017

Topics: Pharmaceuticals

Authors: Dat Tran, Ilke Akpinar, Richard Fedorak, Egon Jonsson, John Mackey, Lawrence Richer, Philip Jacobs

ISSN (online): 1482-1826

Journal Title: Journal of Pharmacy & Pharmaceutical Sciences

Volume: 20

Issue: 1

Pages: 407-414